Dr. Nalini Mohan Koutha

Dr. Nalini Mohan Koutha
Dr. Nalini is a Pharmaceutical patent expert and has extensive experience as a technical and Intellectual Property Specialist in Generic Pharmaceutical manufacturing. His quest for analytical thinking extends to his deep interest in philately.

From Addiction to Wonder Drug, Will Opioids Win this Battle?

Featured image source: http://maxpixel.freegreatpicture.com/Garden-Poppy-Raw-Pods-Papaver-Capsules-Opium-87112

Pain treatment is a subject that has garnered ample attention from the medical fraternity since the days of recorded medical history. From the times of Sushruta till the era of IoT, treating pain in its various formats has kept researchers’ interest alive. Opium in its natural and synthetic forms has been used in the past to treat pain. Opiate, an […]

Is it a must-win for Biogen over Forward Pharma?

Featured image source: https://www.pexels.com/photo/dark-purple-black-medicine-119931/

Biogen has had a news-breaking start to the year, first with Michael Vounatsos taking over as the CEO of the company; and second, with Vounatsos announcing a payout of $1.25 billion to Forward Pharma to settle a patent licensing agreement. Vounatos has been quoted in the media as saying this will help strengthen Biogen’s intellectual property and protect its drug […]

Why Should You Kill Patents?

Featured image source: http://www.aerenip.com/images/slide-pic.jpg

Renewing a patent is a major decision that individual patent assignees and companies need to make. Generally, utility patents expire after 20 years from the application filing date if the maintenance fee is not paid, thus no longer protecting it from enforcement. Nearly all patent application owners have limited budgets for patent validations and renewals. Hence, their primary consideration is […]

Decoding India’s Section 3(d) Pharma Controversy

Source: http://tabletkinaodchudzanie.bblog.pl/i/blog/users/158355/files/Image/14.jpg

India owns the third largest pharmaceutical industry in the world in terms of volume and is the 14th largest in terms of value. It has joined hands with those of China, Brazil, Russia and 13 other countries to create a pool of pharmerging countries. This pool is expected to contribute nearly 50% of the world’s annual pharmaceutical market growth. While India […]

Sterile Salmon on your Plate, and You Wouldn’t Know

Featured image source: https://static.pexels.com/photos/36768/food-salmon-teriyaki-cooking.jpg

Biotechnology is going heads-on into unexplored waters. After bioluminescent plants, there’s another surprise in store for the common man. The US Food and Drug Administration, popular as FDA, recently approved a genetically engineered salmon that grows twice as fast as its natural counterparts on 25 per cent lesser food, and is sterile. The brainchild of AquaBounty, the AquaAdvantage project involves […]

Deuterated Drugs set to Explode in Patent Battles

Source: http://www.farmaceuticas.com.br/wp-content/uploads/2014/11/formula.jpg

Circa 2015 created a flutter of excitement in the pharmaceutical world when scientists unearthed patents filed in the 1970s and found it supporting the claims of a modified drug manufactured in the USA. The SD-809 drug is a deuterated drug that is awaiting the FDA’s approval to get on shelves and help cure palsy in patients affected by Huntington’s chorea. […]

Training Eagles to Take Down Drones

Featured image source: https://www.flickr.com/photos/thespeakernews/23322727363

Drones are raising the dust of interest among e-commerce and logistics companies. But they are sure becoming a pain point for the airline industry. Drones, officially called unmanned aerial vehicles (UAVs) are cluttering airspaces across several parts of the world, nearly turning into unsafe aerial vehicles. The latest of these precarious incidents includes an American Airlines flight that was landing […]